Characteristics of evodiamine-exerted stimulatory effects on rat jejunal contractility
This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM) increased normal jejunal contractility and jejunal hypocontractility established under a variety of experimental conditions. Evodiamine-exerted...
Saved in:
Published in | Natural product research Vol. 29; no. 4; pp. 388 - 391 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Taylor & Francis
16.02.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1478-6419 1478-6427 1478-6427 |
DOI | 10.1080/14786419.2014.947485 |
Cover
Loading…
Abstract | This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM) increased normal jejunal contractility and jejunal hypocontractility established under a variety of experimental conditions. Evodiamine-exerted stimulatory effects were blocked by the L-type Ca
2+
channel blocker nifedipine or abolished in the Ca
2+
-free assay condition. The stimulatory effects of evodiamine on jejunal contractility were partially blocked in the presence of neurotoxin tetrodotoxin or endogenous acetylcholine synthesis blocker hemicholinium-3 or muscarinic receptor antagonist atropine, respectively. Evodiamine-exerted stimulatory effects were blocked by c-kit receptor tyrosine kinase inhibitor imatinib. Evodiamine increased myosin phosphorylation in jejunal smooth muscle of constipation-prominent rats. These results showed that evodiamine-exerted stimulatory effects on jejunal segments are Ca
2+
-dependent, need the presence of interstitial cell of Cajal, requirement of cholinergic neuron and correlate with increased myosin phosphorylation, implicating the potential value of evodiamine in relieving hypo-motility disorders. |
---|---|
AbstractList | This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5–80.0 μM) increased normal jejunal contractility and jejunal hypocontractility established under a variety of experimental conditions. Evodiamine-exerted stimulatory effects were blocked by the L-type Ca ²⁺ channel blocker nifedipine or abolished in the Ca ²⁺-free assay condition. The stimulatory effects of evodiamine on jejunal contractility were partially blocked in the presence of neurotoxin tetrodotoxin or endogenous acetylcholine synthesis blocker hemicholinium-3 or muscarinic receptor antagonist atropine, respectively. Evodiamine-exerted stimulatory effects were blocked by c-kit receptor tyrosine kinase inhibitor imatinib. Evodiamine increased myosin phosphorylation in jejunal smooth muscle of constipation-prominent rats. These results showed that evodiamine-exerted stimulatory effects on jejunal segments are Ca ²⁺-dependent, need the presence of interstitial cell of Cajal, requirement of cholinergic neuron and correlate with increased myosin phosphorylation, implicating the potential value of evodiamine in relieving hypo-motility disorders. This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM) increased normal jejunal contractility and jejunal hypocontractility established under a variety of experimental conditions. Evodiamine-exerted stimulatory effects were blocked by the L-type Ca(2+) channel blocker nifedipine or abolished in the Ca(2+)-free assay condition. The stimulatory effects of evodiamine on jejunal contractility were partially blocked in the presence of neurotoxin tetrodotoxin or endogenous acetylcholine synthesis blocker hemicholinium-3 or muscarinic receptor antagonist atropine, respectively. Evodiamine-exerted stimulatory effects were blocked by c-kit receptor tyrosine kinase inhibitor imatinib. Evodiamine increased myosin phosphorylation in jejunal smooth muscle of constipation-prominent rats. These results showed that evodiamine-exerted stimulatory effects on jejunal segments are Ca(2+)-dependent, need the presence of interstitial cell of Cajal, requirement of cholinergic neuron and correlate with increased myosin phosphorylation, implicating the potential value of evodiamine in relieving hypo-motility disorders.This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM) increased normal jejunal contractility and jejunal hypocontractility established under a variety of experimental conditions. Evodiamine-exerted stimulatory effects were blocked by the L-type Ca(2+) channel blocker nifedipine or abolished in the Ca(2+)-free assay condition. The stimulatory effects of evodiamine on jejunal contractility were partially blocked in the presence of neurotoxin tetrodotoxin or endogenous acetylcholine synthesis blocker hemicholinium-3 or muscarinic receptor antagonist atropine, respectively. Evodiamine-exerted stimulatory effects were blocked by c-kit receptor tyrosine kinase inhibitor imatinib. Evodiamine increased myosin phosphorylation in jejunal smooth muscle of constipation-prominent rats. These results showed that evodiamine-exerted stimulatory effects on jejunal segments are Ca(2+)-dependent, need the presence of interstitial cell of Cajal, requirement of cholinergic neuron and correlate with increased myosin phosphorylation, implicating the potential value of evodiamine in relieving hypo-motility disorders. This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM) increased normal jejunal contractility and jejunal hypocontractility established under a variety of experimental conditions. Evodiamine-exerted stimulatory effects were blocked by the L-type Ca 2+ channel blocker nifedipine or abolished in the Ca 2+ -free assay condition. The stimulatory effects of evodiamine on jejunal contractility were partially blocked in the presence of neurotoxin tetrodotoxin or endogenous acetylcholine synthesis blocker hemicholinium-3 or muscarinic receptor antagonist atropine, respectively. Evodiamine-exerted stimulatory effects were blocked by c-kit receptor tyrosine kinase inhibitor imatinib. Evodiamine increased myosin phosphorylation in jejunal smooth muscle of constipation-prominent rats. These results showed that evodiamine-exerted stimulatory effects on jejunal segments are Ca 2+ -dependent, need the presence of interstitial cell of Cajal, requirement of cholinergic neuron and correlate with increased myosin phosphorylation, implicating the potential value of evodiamine in relieving hypo-motility disorders. This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM) increased normal jejunal contractility and jejunal hypocontractility established under a variety of experimental conditions. Evodiamine-exerted stimulatory effects were blocked by the L-type Ca(2+) channel blocker nifedipine or abolished in the Ca(2+)-free assay condition. The stimulatory effects of evodiamine on jejunal contractility were partially blocked in the presence of neurotoxin tetrodotoxin or endogenous acetylcholine synthesis blocker hemicholinium-3 or muscarinic receptor antagonist atropine, respectively. Evodiamine-exerted stimulatory effects were blocked by c-kit receptor tyrosine kinase inhibitor imatinib. Evodiamine increased myosin phosphorylation in jejunal smooth muscle of constipation-prominent rats. These results showed that evodiamine-exerted stimulatory effects on jejunal segments are Ca(2+)-dependent, need the presence of interstitial cell of Cajal, requirement of cholinergic neuron and correlate with increased myosin phosphorylation, implicating the potential value of evodiamine in relieving hypo-motility disorders. |
Author | Wang, Jing-Yu Lv, Bo-Chao Lin, Yuan Xiong, Yong-Jian Liu, Fang-Fei Chen, Da-Peng Peng, Jin-Yong |
Author_xml | – sequence: 1 givenname: Yong-Jian surname: Xiong fullname: Xiong, Yong-Jian organization: Pharmaceutical College, Dalian Medical University – sequence: 2 givenname: Da-Peng surname: Chen fullname: Chen, Da-Peng organization: Pharmaceutical College, Dalian Medical University – sequence: 3 givenname: Jin-Yong surname: Peng fullname: Peng, Jin-Yong organization: Pharmaceutical College, Dalian Medical University – sequence: 4 givenname: Jing-Yu surname: Wang fullname: Wang, Jing-Yu organization: Laboratory Animal Center, Dalian Medical University – sequence: 5 givenname: Bo-Chao surname: Lv fullname: Lv, Bo-Chao organization: Pharmaceutical College, Dalian Medical University – sequence: 6 givenname: Fang-Fei surname: Liu fullname: Liu, Fang-Fei organization: Pharmaceutical College, Dalian Medical University – sequence: 7 givenname: Yuan surname: Lin fullname: Lin, Yuan email: linyuandmu2008@qq.com organization: Pharmaceutical College, Dalian Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25112370$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkU9v1DAQxS3Uiv6Bb4BQjlyyeBwnWXOp0AoKUqVegKs1ccbCK8cuttOy355st8uBAz3NaOb3nkbzLthJiIEYewN8BXzN34Ps150EtRIc5ErJXq7bF-x8P647KfqTvz2oM3aR85ZzAW3bvmRnogUQTc_P2Y_NT0xoCiWXizO5irai-zg6nFygmn5TKjRWy26aPZaYdhVZS6YsZKgSlmpL2zmgr0wMZe_kvCu7V-zUos_0-qlesu-fP33bfKlvbq-_bj7e1KZtRKmtNGSNkVwpgUoCDByGfhADWimoJ9WNAs2wBpDD0OJycmdRkQRphZB901yydwffuxR_zZSLnlw25D0GinPWsDAttFyo59FOctmrjncL-vYJnYeJRn2X3IRpp49vW4APB8CkmHMiq40rWNzjC5zXwPU-I33MSO8z0oeMFrH8R3z0f0Z2dZC5YGOa8CEmP-qCOx-TTRiMy7r5r8Mfh0WoJg |
CitedBy_id | crossref_primary_10_2739_kurumemedj_MS682019 crossref_primary_10_1016_j_bioactmat_2020_12_016 crossref_primary_10_1016_j_jep_2020_113164 crossref_primary_10_1097_MD_0000000000030096 crossref_primary_10_1155_2020_8610653 crossref_primary_10_1016_j_phymed_2024_155851 crossref_primary_10_1097_MD_0000000000012438 crossref_primary_10_2147_DDDT_S298954 crossref_primary_10_1016_j_lfs_2018_08_003 |
Cites_doi | 10.1540/jsmr.47.111 10.1146/annurev.physiol.68.040504.094718 10.1111/j.1349-7006.2003.tb01358.x 10.1042/CS19980040 10.3390/md10020281 10.1097/01.scs.0000180285.51365.55 10.1210/en.2007-0467 10.3390/molecules18021826 10.1152/advan.00025.2003 10.1016/S0014-2999(02)02687-0 10.1080/14786419.2011.607452 10.1007/s002109900128 10.1136/gut.2.2.168 10.1055/s-2003-39701 |
ContentType | Journal Article |
Copyright | 2014 Taylor & Francis 2014 |
Copyright_xml | – notice: 2014 Taylor & Francis 2014 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
DOI | 10.1080/14786419.2014.947485 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1478-6427 |
EndPage | 391 |
ExternalDocumentID | 25112370 10_1080_14786419_2014_947485 947485 |
Genre | Short Communication Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .7F .QJ 0BK 0R~ 29M 30N 36B 4.4 53G 5VS AAENE AAHBH AAJMT AALDU AAMIU AAPUL AAQRR ABCCY ABFIM ABHAV ABLIJ ABPAQ ABPEM ABTAI ABXUL ABXYU ACGEJ ACGFS ACIWK ACPRK ACTIO ADCVX ADGTB ADXPE AEISY AENEX AEOZL AFKVX AFRAH AGDLA AGMYJ AHDZW AIJEM AJWEG AKBVH AKOOK ALMA_UNASSIGNED_HOLDINGS ALQZU AQRUH AVBZW AWYRJ BLEHA CCCUG CE4 CS3 DGEBU DKSSO DU5 EBD EBS EJD EMB EMOBN E~A E~B F5P GTTXZ H13 HF~ HZ~ H~P J.P KYCEM M4Z MK0 NA5 NW0 O9- RIG RNANH ROSJB RTWRZ S-T SNACF SV3 TBQAZ TCY TFL TFT TFW TTHFI TUROJ TWF UT5 UU3 ZGOLN ~S~ AAGDL AAHIA AAYXX ADYSH AFRVT AIYEW AMPGV CITATION AAAJW AAPPP ABKVM ABZMO ACYAP ADOGB AFFNX AFWJF BDVFT BKMSO CAG CGR COF CUY CVF CXCUG ECM EIF LJTGL NPM OEUFU 7X8 TASJS 7S9 L.6 |
ID | FETCH-LOGICAL-c532t-f4cefcc40992a9411b01b7b2baf42e7e96d2acb8114bb5a2376fa9e414f224733 |
ISSN | 1478-6419 1478-6427 |
IngestDate | Wed Jul 02 04:41:59 EDT 2025 Mon Jul 21 11:15:30 EDT 2025 Thu Apr 03 07:04:17 EDT 2025 Tue Jul 01 00:17:50 EDT 2025 Thu Apr 24 23:10:52 EDT 2025 Wed Dec 25 09:02:32 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Evodia rutaecarpa cholinergic nervous evodiamine stimulatory effects Ca2 jejunal contractility |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c532t-f4cefcc40992a9411b01b7b2baf42e7e96d2acb8114bb5a2376fa9e414f224733 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25112370 |
PQID | 1640479606 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_1733515029 crossref_citationtrail_10_1080_14786419_2014_947485 informaworld_taylorfrancis_310_1080_14786419_2014_947485 pubmed_primary_25112370 proquest_miscellaneous_1640479606 crossref_primary_10_1080_14786419_2014_947485 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-02-16 |
PublicationDateYYYYMMDD | 2015-02-16 |
PublicationDate_xml | – month: 02 year: 2015 text: 2015-02-16 day: 16 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Natural product research |
PublicationTitleAlternate | Nat Prod Res |
PublicationYear | 2015 |
Publisher | Taylor & Francis |
Publisher_xml | – name: Taylor & Francis |
References | cit0011 cit0001 cit0010 Rasul A (cit0009) 2012; 27 Webb RC (cit0012) 2003; 27 Fujii T (cit0004) 1997; 16 Lee JS (cit0006) 2013; 17 cit0008 cit0017 cit0007 cit0015 cit0016 cit0005 cit0002 cit0013 cit0003 cit0014 |
References_xml | – ident: cit0016 doi: 10.1540/jsmr.47.111 – ident: cit0017 doi: 10.1146/annurev.physiol.68.040504.094718 – ident: cit0003 doi: 10.1111/j.1349-7006.2003.tb01358.x – ident: cit0007 doi: 10.1042/CS19980040 – ident: cit0008 doi: 10.3390/md10020281 – volume: 16 start-page: 436 year: 1997 ident: cit0004 publication-title: Pharm Biol – ident: cit0010 doi: 10.1097/01.scs.0000180285.51365.55 – ident: cit0011 doi: 10.1210/en.2007-0467 – ident: cit0015 doi: 10.3390/molecules18021826 – volume: 27 start-page: 201 year: 2003 ident: cit0012 publication-title: Adv Physiol Educ doi: 10.1152/advan.00025.2003 – volume: 17 start-page: 421 year: 2013 ident: cit0006 publication-title: Nat Prod Res – ident: cit0013 doi: 10.1016/S0014-2999(02)02687-0 – volume: 27 start-page: 1481 year: 2012 ident: cit0009 publication-title: Oncol Rep – ident: cit0002 doi: 10.1080/14786419.2011.607452 – ident: cit0014 doi: 10.1007/s002109900128 – ident: cit0001 doi: 10.1136/gut.2.2.168 – ident: cit0005 doi: 10.1055/s-2003-39701 |
SSID | ssj0021555 |
Score | 2.0582838 |
Snippet | This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM)... This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5-80.0 μM)... This study was designed to characterise the effects of evodiamine on intestinal contractility and reveal the correlated mechanisms. Evodiamine (2.5–80.0 μM)... |
SourceID | proquest pubmed crossref informaworld |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 388 |
SubjectTerms | acetylcholine Animals antagonists atropine calcium Calcium - metabolism Calcium Channel Blockers - pharmacology cholinergic nervous Evodia rutaecarpa evodiamine Gastrointestinal Motility - drug effects jejunal contractility jejunum Jejunum - drug effects Molecular Structure Muscle Contraction - drug effects myosin Myosins - metabolism neurons Nifedipine - pharmacology Phosphorylation Quinazolines - pharmacology Rats receptor protein-tyrosine kinase smooth muscle stimulatory effects tetrodotoxin Tetrodotoxin - pharmacology |
Title | Characteristics of evodiamine-exerted stimulatory effects on rat jejunal contractility |
URI | https://www.tandfonline.com/doi/abs/10.1080/14786419.2014.947485 https://www.ncbi.nlm.nih.gov/pubmed/25112370 https://www.proquest.com/docview/1640479606 https://www.proquest.com/docview/1733515029 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELYgPcAF8SblISNxi1xir_d1rFJQVImKQwspl5XttatUdDeiCQd-PTNr72aTPnhcnMheO9F8k8nMeB6EvMvLrJRClGCbpAaGzLE8S0oUhkmqQD-WGm90Px0l0xN5OItn63DbJrtkqffMr2vzSv4HVZgDXDFL9h-Q7Q6FCXgP-MIICMP4VxhPtqotg-Jnf9Yl5mpXlmE3JdQnYe0Cm3ThbXoXvlGNAPrRuT1fVU2FEPTxguhDpbyvrx4pX5dj4QvDjkJtoM6HPJuHkN5TeGWHPV6bhLSPA8U-2_D32IjgEAI8rxjuWTv0u_kzdrrqOyN4k9zNQylrL0AlWKVg06R9CRt8GvO--6ARl5Fv6XdFjPu4RzwrkRzTibjcy2UqfXefHrKLiwZatJNE5DuQbJXPbpfukh0BloQYkJ396cG3r51VDgpV3OZUZuP3130oVowOx2yoLxvFbW82URpV5fgheRBsDLrvGeYRuWOrx-TepG3t94R82WIcWjt6lXFoj3FoYBxaVxQYhwbGoRuM85ScfPxwPJmy0GCDmTgSS-aksc4YMPFzoXLJuR5znWqhlZPCpjZPSqGMzsBm1jpWGEDlVG4llw40vzSKnpFBVVf2BaEqc6lLIm6BfDJxLtMiH8cmM6WCk3Q5JFFLt8KE6vPYBOV7wUOR2pbwBRK-8IQfEtbtWvjqK394PutDUiwbr5fzLWqK6Patb1v4CkADr81UZevVZcETiX0YwNK_5RkgBlgGY5EPyXOPffeFW9bZvXHlJbm__jG9IoPlj5V9DbruUr8J3Pobw2eliw |
linkProvider | Library Specific Holdings |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELYoHOil9N2FtrgS12xjx_HjiFZF2wJ7AsTNsh37AG1SQbZS--s7k8eqiwSV2ksufsQev-azZ74h5MBUuhKcV4BNVICPTpnRssLNUCoH-rHw-KJ7upDzc_HlshytCW8Hs0rE0Kkniuj2alzceBk9msR9ZEJpKRj6mTAxNUIJXT4iW6WRCoMYFPlihbnguCw7ByMAS1hk9J67p5a102mNu_R-DbQ7iY52iB_70BugXE-XrZ-GX3foHf-rk0_Jk0FPpYf9xHpGNmL9nGzPxvBwL8jFbJ3qmTaJxh9NhY7idcwwlBMosxTSvmGEsObmJx1sR2hTU5h39CpeLfEfnbU8-lcgInhJzo8-nc3m2RCkIQtlwdssiRBTCAATDXdGMOZz5pXn3iXBo4pGVtwFrwF3eV86NMJJzkTBRALtQRXFK7JZN3V8Q6jTSSVZsAg9FzIl7bnJy6BD5aAmX01IMQ6ODQODOQbS-GrZQHQ6ysyizGwvswnJVqW-9wwef8mv_xx323Y3J6kPc2KLh4t-GOeIhdHApxdXx2Z5awGUIpc_oMUH8oAwQLvMuZmQ1_0EWzUYgSCILt_998btk-352emJPfm8ON4jjyGlc81n8i3ZbG-W8R0oV61_3y2f399SFmY |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagSMCl5d0tBYzENUvsOI59RNuuymvFgaLeLD8PpU2qNotEf31n8lh1kVokuOTiR-Lx2J4vnvmGkHc6qCA4D4BNKg8PlTKtZMDNUFYW7GPh8Eb360IeHIpPR-XRtSh-dKtEDJ16oohur8bFfRbS6BH3nolKScEwzISJqRaVUOVdck8idzgGceSLFeSC07Ls4osAK2GTMXjuhl7WDqc16tKbDdDuIJpvETsOofc_-Tldtm7qL_9gd_yfMT4im4OVSj_0avWY3In1E_JgNiaHe0p-zNaJnmmTaPzVBAwTr2OGiZzAlKVQdor5wZrz33TwHKFNTUHr6HE8XuI7Ol95jK5APPCMHM73v88OsiFFQ-bLgrdZEj4m7wEkam61YMzlzFWOO5sEj1XUMnDrnQLU5Vxp0QUnWR0FEwlsh6oonpONuqnjNqFWpSrJgkUYuZApKcd1Xnrlg4WeXJiQYpwb4wf-ckyjcWLYQHM6ysygzEwvswnJVq3Oev6Ov9RX16fdtN1_k9QnOTHF7U3fjipiYDbw4sXWsVleGICkyOQPWPGWOiAMsC1zrifkRa9fqw9GGAiiy3f-_ePekPvf9ubmy8fF55fkIRR0cflM7pKN9nwZX4Fl1brX3eK5AlmBFQo |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characteristics+of+evodiamine-exerted+stimulatory+effects+on+rat+jejunal+contractility&rft.jtitle=Natural+product+research&rft.au=Xiong%2C+Yong-Jian&rft.au=Chen%2C+Da-Peng&rft.au=Peng%2C+Jin-Yong&rft.au=Wang%2C+Jing-Yu&rft.date=2015-02-16&rft.eissn=1478-6427&rft.volume=29&rft.issue=4&rft.spage=388&rft_id=info:doi/10.1080%2F14786419.2014.947485&rft_id=info%3Apmid%2F25112370&rft.externalDocID=25112370 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6419&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6419&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6419&client=summon |